feed,title,long_url,short_url
FDA:MedWatch,Ukoniq (umbralisib): Drug Safety Communication - FDA Investigating Possible Increased Risk of Death with Lymphoma,http://www.fda.gov/safety/medical-product-safety-information/ukoniq-umbralisib-drug-safety-communication-fda-investigating-possible-increased-risk-death-lymphoma,https://bit.ly/3omemfY
